NCT01908283View on ClinicalTrials.gov

Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions
Inflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative
Interventions
BIOLOGICAL

13-valent pneumococcal conjugated vaccine (PCV13)

Immunization with 1 dose of PCV13 (=0.5ml) intra-muscular

Trial Locations (1)

1211

University Hospitals of Geneva, Geneva

All Listed Sponsors
collaborator

Swiss IBD Cohort Study

UNKNOWN

lead

Klara M. Pósfay Barbe

OTHER

NCT01908283 - Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter